Background/Aims: About 400 million individuals are chronically infected with hepatitis B virus, at high risk of developing liver cirrhosis and hepatocellular carcinoma. Recent studies have demonstrated an interaction between hepatitis B virus replication and autophagy activity of hepatocytes. In the present study, we aimed to investigate the role of miR-141 in regulating autophagy and hepatitis B virus replication. Methods: The expression of HBV-DNA, miR-141 and Sirt1 mRNA was determined by quantitative real-time PCR analysis. The expression of HBsAg and HBeAg was determined by ELISA. Western blotting was performed to detect protein expression. The LC3 puncta was determined by immunofluorescence. To test whether miR-141 directly regulate the expression level of Sirt1 mRNA, dual-luciferase reporter gene assay was performed. Results: In vitro studies showed that miR-141 mimic inhibited the autophagic response, hepatitis B virus and the expression of Sirt1 in hepatocytes.
MicroRNA

Introduction
Hepatitis B virus (HBV) belongs to the family Hepadnavirus [1] . HBV causes 400 million chronic HBV infection (CHB), which is correlated with the development of liver cirrhosis and hepatocellular carcinoma (HCC) [2] [3] [4] . However, the current two types of approved antiviral therapies cannot completely prevent liver diseases, only a limited number of patients achieve HBsAg loss, which is considered a "functional cure". During HBV infection, host cellular components and machinery must be utilized to complete replication and mediate pathogenesis [5] . However, the details of the host-virus interactions such as autophagy worth to be further clarified. To investigate the complex network of interactions with the host in the course of HBV infection is helpful to define new targets for antiviral strategies [6] .
Autophagy, an evolutionarily conserved intracellular process, engulfs long-lived proteins and damaged organelles for degradation and recycling [5] . The intracellular process of autophagy has been exploited by HBV [7, 8] . Sirt1, the most widely studied sirtuin, plays an important role in regulating the autophagy by deacetylation of autophagy-related proteins [9] . In addition, it has been shown that Sirt1 may facilitate HBV replication in hepatocytes, and target proteins implicated in HBV core promoter transcriptional regulation, especially PGC-1α and FXR [10, 11] .
miRNAs are a class of highly conserved small non-coding RNAs, which are key regulators of gene expression by targeting mRNAs, leading to translation repression or degradation [12] . It has been reported that miRNAs are involved in autophagy regulation [13] . In addition, studies show miR-141 inhibits various kinds of virus infection, such as HBV. Therefore, we hypothesized whether hsa-miR-141 inhibits HBV through inhibition of autophagy mediated by Sirt1.
The present study demonstrated the potential role of miR-141 in modulating autophagy. Our findings demonstrated overexpression of miR-141 inhibited autophagy, thus facilitating the inhibition of HBV. Further, Sirt1 was identified as a novel target of miR-141 in HBV inhibition. These findings provide a novel perspective in the host-virus relationship in HBV infection.
Materials and Methods
Antibodies and reagents
The following antibodies or reagents were used: Sirt1 (Abcam, Cambridge, MA, USA); antibody against p62 (MBL International, Nagoya, Japan) ; antibody to LC3 (Sigma, Spruce, St. Louis, USA) and antibody to β-actin (Santa Cruz, Dallas, TX, USA); Alexa Fluor 488-conjugated secondary Antibody (Molecular Probes, Junction, OR, USA), DAPI (Molecular Probes, Junction, OR, USA), Rapamycin (Rap, Sigma, Spruce, St. Louis, USA), 3-methyladenine (3-MA) and chloroquine (CQ) (Sigma, Spruce, St. Louis, USA). Rap (100 nM) exposure was for 24h, and Rap (50 nM) exposure was for 48h used as a positive control. In terms of the autophagic flux, 5 mM 3-MA and 20 μM CQ was added to the medium 12h before cell harvest. In other aspects, 10 mM 3-MA was added to the medium 2h before cell harvest. miR-141 mimic (20nM) or miR-141 inhibitor (20nM) or miR-141 mimic negative control (MMNC, 20nM) or miR-141 inhibitor negative control (MINC, 20nM) were from Ribobio (Guangzhou, China).
Immunofluorescence
Cells were grown on glass coverslips in 24-well plates as described previously [19] . For GFP-LC3 dots, cells were fixed with 4% paraformaldehyde followed by permeabilization with 0.3% Triton X-100. For LC3 staining, after cells were fixed and permeabilized, cells were incubated with primary LC3 antibody and then Alexa Fluor 488-conjugated secondary Antibody. The cells were fixed in 4% paraformaldehyde for 15min and viewed by confocal microscopy (Olympus Inc., Center Valley, PA, USA). The exposure time for immunofluorescent detection is 1/2.2 s. The nucleus was stained with DAPI if necessary. Approximately 50 cells in each group were counted. The percentage of cells with GFP-LC3 or LC3 was determined using the Image-Pro Plus 5.0 software (Media Cybernetics, Inc., Bethesda, MD, USA).
Western-blot analysis
Cells were washed with ice-cod PBS, and the cell lysates were prepared using RIPA lysis buffer containing a protease inhibitor PMSF. The protein content of different fractions was determined by a BCA method (Thermo Scientific , Grand Island, NY, USA). Equivalent amounts of protein (20μg) were separated by 12% SDS-PAGE and transferred to a polyvinylidene difluoride membrane (PVDF, Millipore, Billerica, MA, USA). The membrane was blocked in 5% nonfat milk in TBST and incubated with primary Antibodies at 4°C overnight. After washing, the membrane was then incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies (Southern Biotechnology Associates, Inc., Birmingham, AL, USA) for 1h at room temperature and visualized with enhanced ECL (Thermo Scientific, Grand Island, NY, USA) following exposure to X-ray films [20] . The relative band intensity was quantified by using the software Image J (NIH, Bethesda, MD, USA) [21] .
Real-time qRT-PCR analysis
RNA was extracted with mirVana TM miRNA Isolation Kit (AM1561, Ambion, Grand Island, NY, USA). For miRNA, the expression levels of hsa-miR-141-3p was detected using Takara kit (PrimeScript TM RT reagent Kit with gDNA Eraser, SYBR Premix EX Taq TM II) with primers Bulge-LoopTM miRNA qRT-PCR Primer Set (Ribobio, Guangzhou, China), and normalized to U6 with primers U6 snRNA qRT-PCR Primer Set (Ribobio, Guangzhou, China). For mRNA, the first-strand cDNA synthesis was performed using Kit (Takara, Dalian, China), then the expression of Sirt1 was assessed by PCR amplification. The primer sequences (Sangon, Shanghai, China) used for PCR were: Sirt1 (NM_012238.4), 5'-GCTGGCCTAATAGAGTGGCAA -3' (forward), 5'-CTCAGCGCCATGGAAAATG -3' (reverse); GAPDH (NM_008084.2), 5'-3' CCATGTTCGTCATGGGTGTGAACCA (forward); 5'-3' GCCAGTAGAGGCAGGGATGATGTTC (reverse). The PCR amplification was performed using the Applied Biosystems 7900 Sequence Detection system (Applied Biosystems, Foster City, CA, USA). The miR-141 and mRNA (Sirt1 and GAPDH) expression was calculated using ∆Ct= (Ct miR-141 -Ct U6 ) and ∆Ct= (Ct Sirt1 -Ct GAPDH ) respectively. The relative expression of miR-141 was calculated using the 2 -∆∆Ct method (∆∆Ct=∆Ct experiment -∆Ct control ) [22] .
Luciferase reporter assays HepG2.2.15 cells were plated in 24-well plates 24 h prior to transfection. pGV306 luciferase reporter plasmids containing either a wide-type or mutated Sirt1 3'UTR were co-transfected with miR-141 mimic or
Results
miR-141 inhibits HBV expression and replication
miR-141 was examined to confirm its inhibition of HBV by co-transfection of Huh7 with HBV1.3 and miR-141 mimic or transfecting miR-141 mimics into HepG2.2.15 cells. As shown in Fig. 1(a-f) , compared to the Mock and MMNC groups, the percentages of HBsAg/HBeAg expression levels and viral DNA were significantly reduced. These data validated that miR-141 could repress HBV.
miR-141 inhibits autophagosome formation
It has been reported that autophagic vacuoles were induced by HBV [24] . We first evaluated the autophagic activity affected by miR-141 to determine the percentage of cells with LC3 puncta.
By using the PI3KC3 inhibitor 3-MA, the enzyme essential for the formation of autophagosomes was inhibited, reducing the autophagy activity. As shown in Fig. 2a and 2b, it is bright and punctate in the presence of HBV (in Mock and MMNC groups), but in the presence of miR-141 mimic or 3-MA, the GFP-LC3 signal is weak. candidate miR-141 binding site in the Sirt1 mRNA 3'-untranslated region (UTRs) (Fig. 4a) . The 3'UTR containing the binding site sequence (160bp) was cloned into pGV306 to construct the reporter plasmid pGV306-Sirt1 (Fig. 5a ). pGV306-Sirt1 vector was co-transfected with miR-141 mimic into HepG2.2.15. Luciferase assay results demonstrated that miR-141 reduced the luciferase activity of pGV306-Sirt1 significantly (Fig. 5b) . TargetScan database showed the seed sequence between hsa-miR-141-3p and the Sirt1 3'UTR (Fig. 4b) . This seed sequence is highly conserved among many kinds of species (Fig. 4c) . Next, Luc reporter containing the seed sequence mutant was constructed, which was called pSirt1-Mut. HepG2.2.15 cells were co-transfected pSirt1-Mut or pSirt1-WT with or without miR-141, then the luciferase reporter activity was assayed. As shown in Fig. 5c , miR-141 mimic did not change reporter activity in cells transfected with pSirt1-Mut, while miR-141 mimic significantly reduced reporter activity in cells transfected with pSirt1-WT. These results above indicated that miR-141 regulated Sirt1 expression by targeting Sirt1 3'-UTR binding site.
miR-141 regulates the expression of Sirt1 mRNA
In addition to miR-141 regulation for the expression levels of Sirt1 protein, we further determined the amount of Sirt1 mRNA mediated by miR-141. Huh7-HBV1.3 cells were transfected with miR-141 mimic or miR-141 inhibitor. Huh7-HBV1.3 cells were treated with 3-MA or Rap as a negative or positive control group. Results (Fig. 6a-6b) showed that miR-141 mimic significantly increased the expression levels of miR-141 but decreased Sirt1 mRNA, however, it was shown that miR-141 inhibitor significantly decreased the expression levels of miR-141 but increased Sirt1 mRNA. These results above demonstrated that miR-141 could also regulate the expression levels of Sirt1 mRNA.
miR-141 inhibits autophagic activity and HBV replication through Sirt1
SIRT1 regulates the autophagy-lysosome pathway by deacetylation of the major regulators of autophagy including ATG8/LC3. To test the hypothesis that miR-141 inhibits autophagy mediated by Sirt1, we evaluated the autophagic activity in HeLa/GFP-LC3 cells transiently transfected with pSirt1 using fluorescence microscopy to test the number of LC3 puncta.
Fluorescence microscopy results (Fig. 7a -7d) showed that transient transfection with pSirt1 activated autophagy in HeLa/GFP-LC3, as suggested by the increased percentage of cells with GFP-LC3 punctate.
Further, results confirmed that Sirt1 promoted HBV replication and expression ( Fig.  8a-8c) . To further test the hypothesis that miR-141 inhibits autophagy mediated by Sirt1, we evaluated the autophagic activity in Huh7-HBV1.3 cells transiently co-transfected with pSirt1 or Vector and miR-141 mimic or MMNC. Western blot was used to determine the amount of Sirt1, the ratios of LC3-II/LC3-I and p62. Results (Fig. 9a-9d) showed that miR-141 mimic or 3-MA significantly reduced the expression levels of Sirt1, the ratios of LC3-II/ LC3-I and p62, as compared to the pSirt1 and the pSirt1 plus MMNC groups. These results validated the hypothesis that miR-141 inhibits autophagy mediated by Sirt1. 
Discussion
Autophagy has been demonstrated to play an important role in HBV replication and pathogenesis. Although it has been reported that the steps in the autophagy pathway are enhanced or subverted by HBV. In Huh7 human hepatoma cells transfected with pEGFP-LC3, the fusion protein of GFP and LC3 is diffusely localized in the cytosol. During autophagy in pHBV1.3-transfected cells (Huh7-HBV1.3), it is localized to autophagosomes. However, the underlying molecular mechanisms remain to be fully demonstrated. Here we reported a novel role of miR-141 in inhibiting autophagy and HBV replication inhibition by targeting Sirt1, which may provide further evidence for host-HBV interaction. was to study HBV replication promotion of Sirt1, and the same group treated with 3-MA was to study the autophagy inhibition on the effect of HBV replication. The vector transfection (Vector, pHBV1.3) and transfection reagent groups (Mock) were used as negative controls. The culture supernatant 48h after transfection was harvested. HBsAg (a) and HBeAg (b) of was determined by ELISA assay, and HBV DNA(c) was detected by qPCR. The results represent the mean data from three independent experiments. *, P< 0.05, **, P< 0.01.
It has been reported that miR-141 mimic inhibited HBV expression and replication [25] in HepG2 cells. The present study confirmed the HBV inhibition of miR-141 in Huh7 cells transfected with pHBV1.3 and HepG2.2.15, consistent with the previous study for HBV replication inhibition [25] . It was reported that miR-141 suppressed HBV replication by reducing HBV promoter activities by down-regulating PPARA [25] . Studies have shown that PPARα activation promotes the autophagy pathway to attenuate the inflammatory response, thus protecting the liver from acute failure [27] and PPARα inhibits cell apoptosis in vascular adventitial fibroblast partly through the SIRT1-mediated deacetylation of FoxO1 [28] .
Several markers of autophagy are well characterized, such as microtubule-associated protein light chain 3 (LC3), which undergoes the formation of LC3 II which is converted from LC3-I [29] . p62/SQSTM1 functions an autophagy adaptor and a selective autophagy receptor. p62 undergoes autophagic degradation and degrades at a basal rate [30, 31] . Notably, our findings showed that miR-141 decreased the accumulation of LC3 puncta and the processing of LC3I to LC3II in HBV1.3 transfected with Huh7 cells, which indicates that miR-141 reduced the autophagic response. Hence, we proposed miR-141 may decrease autophagy response to inhibit HBV replication. Further, the autophagic flux experiment confirmed the autophagy inhibition of miR-141. Autophagy, which was discovered in the liver, is a highly conserved recycling process regulating a number of cell functions including liver metabolism [32, 33] . The pathogenesis of various hepatic diseases (including viral hepatitis, hepatocellular carcinoma, and fatty liver) involved the dysregulation of autophagy [34, 35] . The autophagy can be activated by pharmacological agonists (e.g., rapamycin) [29] or inhibited by pharmacological inhibitors (3-MA) [36] . Emerging evidence has shown that HBV replication appeared to depend on the autophagy machinery [37] in vitro study or in vivo.
Sirt1, which is the most widely studied sirtuin, regulates several biological processes including autophagy and cell metabolism [38, 39] . Sirt1 -/-mice displayed impaired autopha- gy, including accumulation of damaged organelles and up-regulation of p62 level [40] . In the present study, we also found that miR-141 down-regulated the expression level of Sirt1, which indicated that miR-141 inhibited autophagy mediated by Sirt1. In addition, we confirmed the autophagic induction of Sirt1 in HeLa/GFP-LC3. The mechanism of Sirt1/autophagy regulation is involved in various kinds of the physiological and pathological process [41, 42] .
The previous study has shown that basal autophagy by deacetylating Atg5, Atg7 and Atg8 was increased by deacetylating Sirt1 [40] . We found that the overexpression of Sirt1 dampened the ability of miR-141 to inhibit autophagic activity in Huh7 transfected with pHBV1.3. Further, Sirt1 is the target of miR-141 which is predicted by TargetScan, and the data from luciferase assay demonstrated that miR-141 bound to the 3'UTR of Sirt1. Together, our data indicated that Sirt1 was a novel target for miR-141. Studies have demonstrated that miR-141 conducted different functions by repressing various kinds of targets, such as transforming growth factor (TGF)-β2 [43] , which targets being related to influenza A H5N1. However, none of these studies about miR-141 was involved in modulating autophagic response.
The study was limited by lack of in vivo study, which might weaken the evidence of HBV inhibition by miR-141. The narrow species, tissue tropism of this virus and the lack of reliable laboratory animals susceptible to HBV infection have limited research [44] .
Collectively, our study indicated that miR-141 inhibited autophagy by targeting Sirt1, conferring inhibitory effect of HBV replication. The present study demonstrated an important role of miR-141 in autophagy regulation and HBV inhibition, which may provide new light on the development of therapeutic strategy against HBV.
